2014 AACI Clinical Research Initiative Meeting Abstract (2 pages)

Document rating:
  3.7 out of 5
Vote this doc:
background image

2014 AACI Clinical Research Initiative Meeting Abstract

Page 2

Findings suggest there are more Kansans with insurance as a result of the ACA mandate; however, this
increase does not yet appear to translate into increased coverage for oncology clinical trial participation.

The ACA mandate does not require all insurance plans, just new policies provided after March 2010, to
cover trial participation, nor does the ACA include details on how to implement this mandate. In fact,
the Kansas Insurance Department is allowing “companies selling health insurance in the state to
continue to renew policies that don’t meet the requirements of the ACA…for policy years beginning on
or before October 1, 2016” (Praeger, 2014). This decision will leave hundreds of thousands of Kansans
with commercial policies without coverage for clinical trial participation for several more years, because
it is up to the individual insurance provider as to whether or not trial participation is a covered benefit.

Future analyses need to be conducted to assess the magnitude of ACA’s impact on clinical trial coverage
over time. Meanwhile, strong advocating and education efforts need to persist for cancer patients and
clinical trial coverage, particularly in the 16 states that lack state laws as well as at the federal level.





Reference

Praeger, S. (2014). Kansas Insurance Quarterly, Winter 2014. Retrieved April 15, 2014, from

http://www.ksinsurance.org/

Document rating:
  3.7 out of 5
Vote this doc: